92 related articles for article (PubMed ID: 3023512)
1. 1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis.
Manolagas SC; Werntz DA; Tsoukas CD; Provvedini DM; Vaughan JH
J Lab Clin Med; 1986 Dec; 108(6):596-600. PubMed ID: 3023512
[TBL] [Abstract][Full Text] [Related]
2. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.
Koren R; Ravid A; Liberman UA; Hochberg Z; Weisman Y; Novogrodsky A
J Clin Invest; 1985 Nov; 76(5):2012-5. PubMed ID: 2997300
[TBL] [Abstract][Full Text] [Related]
3. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production.
Provvedini DM; Tsoukas CD; Deftos LJ; Manolagas SC
J Immunol; 1986 Apr; 136(8):2734-40. PubMed ID: 3007606
[TBL] [Abstract][Full Text] [Related]
4. 1 alpha,25-Dihydroxyvitamin D3 receptors in human thymic and tonsillar lymphocytes.
Provvedini DM; Rulot CM; Sobol RE; Tsoukas CD; Manolagas SC
J Bone Miner Res; 1987 Jun; 2(3):239-47. PubMed ID: 2843004
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation.
Bhalla AK; Amento EP; Serog B; Glimcher LH
J Immunol; 1984 Oct; 133(4):1748-54. PubMed ID: 6206136
[TBL] [Abstract][Full Text] [Related]
6. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D affects proliferation of a murine T helper cell clone.
Lacey DL; Axelrod J; Chappel JC; Kahn AJ; Teitelbaum SL
J Immunol; 1987 Mar; 138(6):1680-6. PubMed ID: 3029220
[TBL] [Abstract][Full Text] [Related]
8. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes.
Provvedini DM; Manolagas SC
J Clin Endocrinol Metab; 1989 Apr; 68(4):774-9. PubMed ID: 2564005
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and the hematolymphopoietic tissue: a 1994 update.
Manolagas SC; Yu XP; Girasole G; Bellido T
Semin Nephrol; 1994 Mar; 14(2):129-43. PubMed ID: 8177980
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.
Nunn JD; Katz DR; Barker S; Fraher LJ; Hewison M; Hendy GN; O'Riordan JL
Immunology; 1986 Dec; 59(4):479-84. PubMed ID: 3026959
[TBL] [Abstract][Full Text] [Related]
11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
12. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.
Eisman JA; Barkla DH; Tutton PJ
Cancer Res; 1987 Jan; 47(1):21-5. PubMed ID: 3024816
[TBL] [Abstract][Full Text] [Related]
13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
14. Expression of 1,25(OH)2D3 receptors on alveolar lymphocytes from patients with pulmonary granulomatous diseases.
Biyoudi-Vouenze R; Cadranel J; Valeyre D; Milleron B; Hance AJ; Soler P
Am Rev Respir Dis; 1991 Jun; 143(6):1376-80. PubMed ID: 1646583
[TBL] [Abstract][Full Text] [Related]
15. 1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes.
Stoeckler JD; Stoeckler HA; Kouttab N; Maizel AL
J Immunol; 1996 Dec; 157(11):4908-17. PubMed ID: 8943395
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1,25-dihydroxyvitamin D3 in vivo on circulating T lymphocytes.
Bargman JM; Silverman ED; Klein MH
Miner Electrolyte Metab; 1989; 15(6):359-64. PubMed ID: 2615722
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects.
Takeuchi A; Reddy GS; Kobayashi T; Okano T; Park J; Sharma S
J Immunol; 1998 Jan; 160(1):209-18. PubMed ID: 9551973
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.
Frampton RJ; Omond SA; Eisman JA
Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
D'Ambrosio D; Cippitelli M; Cocciolo MG; Mazzeo D; Di Lucia P; Lang R; Sinigaglia F; Panina-Bordignon P
J Clin Invest; 1998 Jan; 101(1):252-62. PubMed ID: 9421488
[TBL] [Abstract][Full Text] [Related]
20. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices.
Freake HC; Abeyasekera G; Iwasaki J; Marcocci C; MacIntyre I; McClelland RA; Skilton RA; Easton DF; Coombes RC
Cancer Res; 1984 Apr; 44(4):1677-81. PubMed ID: 6322984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
